Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 953 - 960 of 12143 results

Recent SEC Rules and Guidance Impose New Obligations on SPACs and Reverse Mergers

May 15, 2024| Alert| Viewpoint

New Legislation Would Expand the Use of Municipal Bonds

May 15, 2024| Alert| Viewpoint

Private Equity Firm Rolled Out of FTC Suit

May 15, 2024| Blog| Viewpoint

House Committee Proposes to Extend Medicare Telehealth Flexibilities, Eyes PBM Reform to Offset Expenses

May 15, 2024| Blog| Viewpoint

5 Takeaways From FERC's Grid Planning Policy Overhaul

May 14, 2024| News

Three Is (Not) A Magic Number: Damages Under the Discovery Rule

May 13, 2024| Blog| Viewpoint

FERC Tees Up Big Transmission Rule

May 13, 2024| News

How Firms Help IP Associates With Pro Bono Work

May 10, 2024| News

News & Press Releases

Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash

September 16, 2025

Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.

Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber

September 15, 2025

Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering

September 12, 2025

Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”

View all News and Press Releases